Forecast: Import of Extracts of Glands for Therapeutic Use to Japan

The forecast for Japan's import of extracts of glands for therapeutic use from 2024 to 2028 shows a steady year-on-year increase. In 2024, this market is valued at $12.163 million, and it is projected to grow incrementally each year, reaching $12.998 million by 2028. This reflects a consistent annual growth rate.

Since we are in 2024, the variations in previous years (2023 data not provided) are not available. Therefore, a direct comparison cannot be defined. However, from the forecasted data starting in 2024, the year-on-year growth averages around 1.8% across the forecast horizon, demonstrating a healthy and predictable rise in imports, aligned with global healthcare demands and innovations in therapeutic uses of gland extracts.

Future trends to watch for include advancements in biotechnology and pharmaceuticals, which could lead to higher demand for these specialized extracts. Market players should also monitor regulatory changes and new supplier agreements that could impact these import dynamics. Furthermore, demographic changes, such as an aging population, are likely to increase the demand for therapeutic uses of these products.